Published in Pediatr Infect Dis J on July 01, 2004
Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics (2010) 1.38
A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. J Exp Med (2013) 1.31
Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol (2009) 1.27
Role of innate immunity in neonatal infection. Am J Perinatol (2013) 1.16
Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am (2009) 1.14
Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. Infect Immun (2011) 1.11
Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults. Crit Care (2014) 1.05
Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol (2014) 1.01
Urinary tract infection in the newborn: clinical and radio imaging studies. Pediatr Nephrol (2007) 0.90
Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis. Pediatr Infect Dis J (2013) 0.86
LPS- and LTA-induced expression of IL-6 and TNF-α in neonatal and adult blood: role of MAPKs and NF-κB. Mediators Inflamm (2014) 0.80
Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis. PLoS One (2014) 0.79
TRIF-dependent innate immune activation is critical for survival to neonatal gram-negative sepsis. J Immunol (2014) 0.78
Attenuated mRNA expression of inflammatory mediators in neonatal rat lung following lipopolysaccharide treatment. J Inflamm Res (2012) 0.75
Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988. BMC Infect Dis (2015) 0.75
Appropriate Use of Vancomycin in NICU Despite Free-for-All Policy. J Pediatr Pharmacol Ther (2016) 0.75
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep (2002) 6.51
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet (2006) 5.56
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med (2002) 4.88
Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics (2002) 4.72
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis (2002) 4.08
Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis (2011) 3.46
An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med (2003) 3.32
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Air pollution and birth weight among term infants in California. Pediatrics (2005) 2.55
Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis (2003) 2.29
Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med (2009) 2.25
US childhood asthma prevalence estimates: the Impact of the 1997 National Health Interview Survey redesign. Am J Epidemiol (2003) 2.12
Superspreading SARS events, Beijing, 2003. Emerg Infect Dis (2004) 2.03
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 2.03
Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis (2005) 2.03
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet (2009) 1.95
Disparities in exposure to air pollution during pregnancy. Environ Health Perspect (2003) 1.89
Racial and income disparities in childhood asthma in the United States. Ambul Pediatr (2002) 1.72
Contextual effect of income inequality on birth outcomes. Int J Epidemiol (2005) 1.71
Perinatal infections due to group B streptococci. Obstet Gynecol (2004) 1.69
Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis (2005) 1.68
Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67
Relationships between air pollution and preterm birth in California. Paediatr Perinat Epidemiol (2006) 1.63
Does postpartum length of stay affect breastfeeding duration? A population-based study. Birth (2003) 1.60
Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 1.59
Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis (2003) 1.58
Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis (2004) 1.57
Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis (2002) 1.53
Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis (2002) 1.53
Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J (2008) 1.50
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis (2003) 1.49
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis (2004) 1.48
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics (2002) 1.47
Measuring health disparities: trends in racial-ethnic and socioeconomic disparities in obesity among 2- to 18-year old youth in the United States, 2001-2010. Ann Epidemiol (2012) 1.44
Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep (2014) 1.44
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis (2004) 1.43
Changing patterns of low birthweight and preterm birth in the United States, 1981-98. Paediatr Perinat Epidemiol (2002) 1.43
Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics (2006) 1.41
A longitudinal view of child enrollment in Medicaid. Pediatrics (2013) 1.38
Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis (2004) 1.37
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health (2010) 1.33
Comparing exposure metrics in the relationship between PM2.5 and birth weight in California. J Expo Anal Environ Epidemiol (2004) 1.32
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32
Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics (2010) 1.26
Invited commentary: what's so bad about curves crossing anyway? Am J Epidemiol (2004) 1.23
Trends in caffeine intake among U.S. children and adolescents. Pediatrics (2014) 1.23
Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet (2005) 1.23
Maternal age and parity-associated risks of preterm birth: differences by race/ethnicity. Paediatr Perinat Epidemiol (2007) 1.21
Fine particulate matter (PM2.5) air pollution and selected causes of postneonatal infant mortality in California. Environ Health Perspect (2006) 1.20
Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol (2003) 1.19
Contribution of excess weight gain during pregnancy and macrosomia to the cesarean delivery rate, 1990-2000. Pediatrics (2003) 1.19
The contribution of preterm birth to the Black-White infant mortality gap, 1990 and 2000. Am J Public Health (2007) 1.18
The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet (2007) 1.17
Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol (2007) 1.17
Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique. Trop Med Int Health (2006) 1.15
Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine (2008) 1.15
Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis (2005) 1.15
Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol (2003) 1.14
Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J Trop Pediatr (2009) 1.13
Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis (2003) 1.13
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011. MMWR Surveill Summ (2011) 1.10
Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. Vaccine (2002) 1.09
Trends in racial and ethnic disparities in infant mortality rates in the United States, 1989-2006. Am J Public Health (2013) 1.08
Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003. Vaccine (2008) 1.03
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. J Infect Dis (2003) 1.00
Implications of cleaning gestational age data. Paediatr Perinat Epidemiol (2002) 0.97
Excess screen time in US children: association with family rules and alternative activities. Clin Pediatr (Phila) (2013) 0.96
Heterogeneity within Asian subgroups: a comparison of birthweight between infants of US and non-US born Asian Indian and Chinese mothers. Matern Child Health J (2007) 0.96
The influence of proximity of prenatal services on small-for-gestational-age birth. J Community Health (2002) 0.92
Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol (2007) 0.92
The influence of maternal age on very preterm birth of twins: differential effects by parity. Paediatr Perinat Epidemiol (2005) 0.89
Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis (2002) 0.89
Sentinel surveillance: a reliable way to track antibiotic resistance in communities? Emerg Infect Dis (2002) 0.88
Excessive maternal weight gain patterns in adolescents. J Am Diet Assoc (2003) 0.88
Streptococcus pneumoniae and Haemophilus influenzae type B Carriage, Central Asia. Emerg Infect Dis (2005) 0.88
Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatr Infect Dis J (2003) 0.87
Public health issues related to infection in pregnancy and cerebral palsy. Ment Retard Dev Disabil Res Rev (2002) 0.87
The effect of birth weight discordance on twin neonatal mortality. Obstet Gynecol (2003) 0.87
Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service. Am J Epidemiol (2011) 0.87
Invasive group-A streptococcal infection in an allograft recipient. A case report. J Bone Joint Surg Am (2007) 0.86
Infections in international pregnancy study: performance of the optical immunoassay test for detection of group B streptococcus. J Clin Microbiol (2003) 0.85
Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. Clin Infect Dis (2004) 0.85
Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections. Emerg Infect Dis (2015) 0.83
Adults with invasive pneumococcal disease: missed opportunities for vaccination. Am J Prev Med (2006) 0.80
Preventive asthma medication discontinuation among children enrolled in fee-for-service Medicaid. J Asthma (2014) 0.80
Implementing an Ebola Vaccine Study - Sierra Leone. MMWR Suppl (2016) 0.79
Delivering pneumococcal vaccine to a high risk population: the Navajo experience. Hum Vaccin (2005) 0.78
From pandemic suspect to the postvaccine era: the Haemophilus influenzae story. Clin Infect Dis (2007) 0.78
Medicaid enrollment gap length and number of Medicaid enrollment periods among US children. Am J Public Health (2014) 0.78
Abdominal adiposity and caregiver recall of healthcare provider identification of child overweight in the United States, 2001-2010. Child Obes (2013) 0.78
Barriers to implementing the group B streptococcal prevention guidelines. Birth (2002) 0.77
Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally. J Pediatr (2013) 0.77